Jose L. Orgaz
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Creating a path during melanoma amoeboid migration: When too crowded, start worrying.
Journal: Developmental cell
Published: July 05, 2024
Cytoskeletal Remodelling as an Achilles' Heel for Therapy Resistance in Melanoma.
Journal: Cells
Published: December 02, 2021
Rho GTPase signaling in cancer progression and dissemination.
Journal: Physiological reviews
Published: September 20, 2021
A preclinical pipeline to evaluate migrastatics as therapeutic agents in metastatic melanoma.
Journal: British journal of cancer
Published: March 24, 2020
What does not kill you makes you stronger: surviving anti-cancer therapies by cytoskeletal remodeling and Myosin II reactivation.
Journal: Molecular & cellular oncology
Published: February 09, 2020
CDC42EP5/BORG3 modulates SEPT9 to promote actomyosin function, migration, and invasion.
Journal: The Journal of cell biology
Published: December 28, 2019
WNT11-FZD7-DAAM1 signalling supports tumour initiating abilities and melanoma amoeboid invasion.
Journal: Nature communications
Published: June 17, 2019
T-type calcium channels drive migration/invasion in BRAFV600E melanoma cells through Snail1.
Journal: Pigment cell & melanoma research
Published: September 21, 2017
Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment.
Journal: Cell
Published: March 22, 2017
Last Updated: 09/26/2026